Patents Assigned to Pharmaco Behavioral Associates, Inc.
  • Transdermal nicotine metabolites and human body weight
    Patent number: 5972974
    Abstract: A therapeutic method is provided to manage human body weight in nicotine-experienced or nicotine-naive individuals, comprising of transdermally administering an amount of nicotine metabolites or a pharmaceutically acceptable salts thereof to a human in need of such treatment, in an amount which is effective to manage human body weight.
    Type: Grant
    Filed: November 7, 1996
    Date of Patent: October 26, 1999
    Assignee: Pharmaco Behavioral Associates, Inc.
    Inventor: Robert M. Keenan
  • Use of cotinine to alleviate tobacco withdrawal syndrome
    Patent number: 5747512
    Abstract: A therapeutic method is provided to alleviate tobacco withdrawal syndrome and/or the symptoms of nicotine withdrawal, comprising administering an amount of cotinine or a pharmaceutically acceptable salt thereof to a human in need of such treatment, which amount is effective to reduce or eliminate at least one of the symptoms of tobacco withdrawal syndrome or nicotine withdrawal.
    Type: Grant
    Filed: August 1, 1996
    Date of Patent: May 5, 1998
    Assignee: Pharmaco Behavioral Associates, Inc.
    Inventors: Robert M. Keenan, Dorothy K. Hatsukami
  • Human body weight management
    Patent number: 5643928
    Abstract: A therapeutic method and article of manufacture to manage human body weight with the use of cotinine or pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: October 21, 1992
    Date of Patent: July 1, 1997
    Assignee: Pharmaco Behavioral Associates, Inc.
    Inventor: Robert M. Keenan
  • Use of cotinine to assist in the cessation of tobacco smoking
    Patent number: 5612357
    Abstract: A pharmaceutical composition is provided that is useful to alleviate various symptoms of tobacco withdrawal syndrome comprising an amount of cotinine or a pharmaceutically acceptable salt thereof in combination with a pharmaceutically acceptable carrier, which amount is effective to reduce or eliminate at least one of the symptoms of tobacco withdrawal syndrome in a human.
    Type: Grant
    Filed: August 22, 1994
    Date of Patent: March 18, 1997
    Assignee: Pharmaco Behavioral Associates, Inc.
    Inventors: Robert M. Keenan, Dorothy K. Hatsukami
  • Therapeutic method to alleviate the craving associated with cessation of tobacco with cotinine
    Patent number: 5596007
    Abstract: A therapeutic method is provided to alleviate tobacco withdrawal syndrome and/or the symptoms of nicotine withdrawal, comprising administering an amount of cotinine or a pharmaceutically acceptable salt thereof to a human in need of such treatment, which amount is effective to reduce or eliminate at least one of the symptoms of tobacco withdrawal syndrome or nicotine withdrawal.
    Type: Grant
    Filed: May 18, 1992
    Date of Patent: January 21, 1997
    Assignee: Pharmaco Behavioral Associates, Inc.
    Inventors: Robert M. Keenan, Dorothy K. Hatsukami